HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Raymond Lai Selected Research
Raymond Lai Research Topics
Disease
95
Neoplasms (Cancer)
09/2023 - 01/2002
37
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2023 - 09/2002
20
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2013 - 12/2002
19
Lymphoma (Lymphomas)
01/2021 - 09/2002
18
Breast Neoplasms (Breast Cancer)
02/2021 - 08/2006
13
Carcinogenesis
06/2018 - 12/2006
7
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2011 - 12/2002
6
Pancreatic Neoplasms (Pancreatic Cancer)
11/2016 - 10/2004
6
Carcinoma (Carcinomatosis)
01/2014 - 06/2005
5
Neoplasm Metastasis (Metastasis)
01/2023 - 07/2012
5
Genetic Translocation (Chromosomal Translocation)
12/2021 - 10/2007
5
Melanoma (Melanoma, Malignant)
01/2018 - 01/2008
5
Leukemia
11/2012 - 06/2005
4
Multiple Myeloma
02/2019 - 02/2008
4
Hypoxia (Hypoxemia)
12/2018 - 04/2013
4
Papillary Thyroid Cancer
10/2016 - 07/2012
4
T-Cell Lymphoma (Lymphoma, T Cell)
11/2013 - 09/2002
4
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2008 - 09/2002
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 01/2002
3
B-Cell Lymphoma (Lymphoma, B Cell)
11/2019 - 09/2007
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2018 - 12/2005
3
Esophageal Squamous Cell Carcinoma
02/2016 - 02/2014
3
Lymphatic Metastasis
01/2014 - 07/2012
3
Adenocarcinoma
11/2010 - 10/2004
2
Mycosis Fungoides
11/2021 - 09/2002
2
Hematologic Neoplasms (Hematological Malignancy)
08/2009 - 01/2002
2
Colorectal Neoplasms (Colorectal Cancer)
07/2009 - 10/2007
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2007 - 09/2006
Drug/Important Bio-Agent (IBA)
47
Proteins (Proteins, Gene)
FDA Link
01/2024 - 09/2002
33
Anaplastic Lymphoma Kinase
IBA
09/2023 - 09/2002
9
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2023 - 01/2004
9
Catenins
IBA
01/2018 - 07/2010
9
Gemcitabine
FDA Link
11/2016 - 10/2004
9
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
05/2016 - 10/2007
9
Cyclin D1
IBA
01/2014 - 12/2002
8
Paraffin
IBA
11/2021 - 09/2003
7
DNA (Deoxyribonucleic Acid)
IBA
10/2017 - 11/2006
7
Equilibrative Nucleoside Transporter 1
IBA
11/2016 - 10/2004
6
Transcription Factors (Transcription Factor)
IBA
07/2021 - 06/2005
6
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
01/2017 - 07/2004
6
Tyrosine (L-Tyrosine)
FDA Link
01/2012 - 09/2003
5
Cytokines
IBA
12/2021 - 08/2005
5
Formaldehyde (Formol)
FDA Link
11/2021 - 09/2003
5
Micelles
IBA
11/2019 - 01/2008
5
Oncogene Proteins (Oncogene Protein)
IBA
08/2019 - 06/2012
5
Small Interfering RNA (siRNA)
IBA
12/2018 - 11/2009
5
Messenger RNA (mRNA)
IBA
01/2015 - 10/2005
5
Nucleoside Transport Proteins (Nucleoside Transporter)
IBA
04/2009 - 10/2004
4
Silybin (Lagosa)
IBA
01/2023 - 05/2016
4
Crizotinib
IBA
01/2021 - 01/2016
4
Rituximab (Mabthera)
FDA Link
11/2019 - 11/2008
4
Cisplatin (Platino)
FDA Link
Generic
10/2017 - 02/2007
4
Protein Isoforms (Isoforms)
IBA
10/2017 - 09/2006
4
MicroRNAs (MicroRNA)
IBA
01/2016 - 08/2013
4
Nucleosides
IBA
01/2014 - 01/2005
4
Tubulin
IBA
12/2008 - 12/2005
3
Interleukin-12 (IL 12)
IBA
01/2023 - 08/2008
3
Ligands
IBA
01/2022 - 07/2010
3
Oligonucleotides
IBA
06/2018 - 09/2006
3
Estrogen Receptors
IBA
02/2018 - 12/2010
3
Paclitaxel (Taxol)
FDA Link
Generic
09/2014 - 12/2005
3
Survivin
IBA
01/2014 - 05/2004
3
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
11/2012 - 10/2006
3
Phosphotransferases (Kinase)
IBA
01/2012 - 09/2006
3
cucurbitacin I
IBA
04/2010 - 10/2006
3
Tissue Inhibitor of Metalloproteinase-1
IBA
08/2006 - 06/2004
3
Complementary DNA (cDNA)
IBA
09/2005 - 09/2003
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
12/2021 - 02/2002
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
10/2021 - 10/2005
2
polyethylene oxide-polycaprolactone copolymer
IBA
11/2019 - 08/2008
2
caprolactone
IBA
11/2019 - 01/2018
2
Apoptosis Regulatory Proteins
IBA
11/2018 - 06/2003
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2017 - 08/2015
2
Fluorouracil (Carac)
FDA Link
Generic
02/2016 - 01/2009
2
Polyethyleneimine
IBA
09/2014 - 10/2011
2
liposomal doxorubicin (Doxil)
FDA Link
11/2013 - 06/2008
2
human ERBB2 protein
IBA
10/2013 - 11/2009
2
Biomarkers (Surrogate Marker)
IBA
10/2013 - 10/2012
2
Glycogen Synthase Kinases
IBA
07/2012 - 12/2010
2
Pyridinolcarbamate (P23)
IBA
01/2012 - 01/2005
2
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
10/2011 - 02/2010
2
Metalloproteases (Metalloproteinases)
IBA
06/2011 - 08/2006
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
07/2010 - 08/2008
2
Somatomedin Receptors (Somatomedin Receptor)
IBA
06/2010 - 07/2009
2
Glycogen Synthase Kinase 3 beta
IBA
01/2010 - 12/2008
2
Immunoglobulins (Immunoglobulin)
IBA
04/2009 - 11/2006
2
Bortezomib (Velcade)
FDA Link
01/2009 - 04/2008
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2009 - 09/2007
2
beta Catenin
IBA
12/2008 - 10/2006
2
fludarabine
IBA
11/2008 - 01/2005
2
Curcumin
IBA
08/2008 - 09/2005
2
Vinorelbine (Navelbine)
FDA Link
Generic
06/2008 - 02/2007
2
NF-kappa B (NF-kB)
IBA
04/2008 - 09/2005
2
Interleukin-6 (Interleukin 6)
IBA
12/2006 - 09/2002
2
ErbB Receptors (EGF Receptor)
IBA
12/2006 - 09/2003
Therapy/Procedure
21
Therapeutics
02/2021 - 09/2003
16
Drug Therapy (Chemotherapy)
01/2023 - 02/2002
4
Immunotherapy
01/2022 - 08/2008
2
Radiotherapy
01/2015 - 04/2009
2
Transplantation
11/2013 - 04/2009